| Oral presentation schedule for October 8 (Thu), Day 1 |
| |
|
Grand Prince Hotel New Takanawa International Convention Center PAMIR |
Grand Prince Hotel Takanawa |
Grand Prince Hotel New Takanawa |
|
|
|
| |
|
Hokushin |
Keiun |
Hakuun |
Suiun |
Kouun |
Aoba |
Matsuba |
Zuiko |
Kyokko |
Gyoko |
Prince Room |
Crown Room |
Ouka |
Sakura |
Heian |
Tenpyo |
Hiten |
Amethyst |
|
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
Commercial Exhibition |
Room 17 |
|
|
8:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
|
|
No planned seminars |
Breakfast
Seminar1
AbbVie GK
New Options for Treatment of Chronic Hepatitis C: DAA-based Treatments including Viekirax Regimen |
Breakfast
Seminar2
SYSMEX CORPORATION
Prevention of HCC after SVR |
No planned seminars |
No planned seminars |
Breakfast
Seminar3
TAISHO TOYAMA PHARMACEUTICAL CO.,LTD.
Pathogenesis and therapeutic strategy of NASH: from the viewpoint of organ network and metabolism
|
Breakfast
Seminar4
Eisai Co., Ltd. / AbbVie GK
Optimaized management of long term IBD therapy |
No planned seminars |
No planned seminars |
No planned seminars |
No planned seminars |
No planned seminars |
|
|
|
|
|
|
|
45 |
|
Opening Ceremony |
|
|
50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9:00 |
|
|
|
|
30 |
|
S1(JSGE/JSH)
New horizons for chronic hepatitis C treatment - Dawn of IFN-free era -
Chair：
S. Nishiguchi
N. Hiramatsu |
W2(JSH/JSGE/JGES/JSGS)
Diagnosis and treatment of portal hypertension
Chair：
S. Kokubu
H. Yoshida |
Integrated Program 1
(JDDW/JGES/JSGE/JSGS)
Walled-off necrosis after necrotizing pancreatitis: What is the best approach?
Chair：
S. Isaji
T. Itoi |
S3(JSH/JSGE/JSGS)
Liver regeneration: Basic to clinic
Chair：
I. Sakaida
G. Shiota |
W3(JSGE/JGES/JSGS)
Diagnosis and treatment of gNET
Chair：
E. Sunami
R. Hokari |
IS-S1(JSH/JSGE/JSGS)
Hepatocellular carcinoma: Molecular approaches for diagnosis, prognosis, and therapy
Chair：
N. Izumi
M. Sakamoto |
Live broadcast Room 1 |
W4(JSGE/JGES/JSH/JSGS)
Pathophysiological significance of intestinal microbiota in digestive disorders
Chair：
Y. Fujiyama
H. Kita
Commentator：
A. Mizoguchi |
PD3(JSGE/JSGS)
Current status of chemo-radiotherapy for esophageal cancer
Chair：
H. Kuwano
Y. Toh |
PD5(JSH/JSGE/JSGS)
Approach the pathophysiology of interdependence between the liver and the other organs
Chair：
M. Hashizume
N. Enomoto |
PD7(JSGCS/JSGE/JGES)
Screening programs for early stage pancreatic cancer and management of high risk individuals
Chair：
G. Kobayashi
S. Okaniwa |
Live broadcast Room 2 |
Live broadcast Room 3 |
|
|
|
Commercial Exhibition |
|
|
|
10:00 |
|
Digital Poster Session
(JSGCS)
9:30-11:30 |
30 |
|
|
|
11:00 |
|
|
|
30 |
|
|
|
12:00 |
|
Lecture by Congress President(JSGCS)
Advances in pancreatic cancer diagnosis
Lecturer：
M. Suyama
Chair：
A. Fukao |
|
|
|
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13:00 |
|
Academic Council
(Japanese Society of Gastroenterology)
12:30-13:40 |
Luncheon
Seminar26
Bristol-Myers K.K. |
Luncheon
Seminar27
ZERIA Pharmaceutical Co., Ltd. / Astellas Pharma Inc.
Q&A on the diagnosis and treatment of Functional Dyspepsia (FD)
-Proper use and problems of the disease name "FD" in the clinical setting- |
Luncheon
Seminar28
AJINOMOTO PHARMA CEUTICALS CO., LTD.
Consideration to the best treatment of Crohn's disease
-Intestinal enviromental factors as a mechanisms to explain exacerbation of colitis- |
Luncheon
Seminar29
DAIICHI SANKYO CO., LTD / AstraZeneca K.K
GERD Award, ・Comparison of the long-term outcomes of endoscopic resection for superficial adenocarcinoma and squamous cell carcinoma of the esophagus in Japan ・Is Barrett’s Carcinoma Always Located Adjacent to Intestinal Metaplasia? –A Histologic Assessment |
Luncheon
Seminar30
Otsuka Pharmaceutical Co., Ltd.
New Therapeutic Options and Strategies For Liver Cirrhosis |
Luncheon
Seminar31
Nippon Kayaku Co.,Ltd.
New Strategy in Transcatheter Arterial Chemoembolization for HCC |
Luncheon
Seminar32
Otsuka Pharmaceutical Co., Ltd. / Takeda Pharmaceutical Company Limited
The forefront of Helicobacter pylori eradication therapy |
Luncheon
Seminar33
AJINOMOTO PHARMA CEUTICALS CO., LTD.
Future Prospects and Challenges in liver disease treatment
- Approach to viral clearance and hepatocarcinogenesis prevention - |
Luncheon
Seminar34
HOYA CORPORATION
To Perform ESD in the Most Effective Way
~Master the Procedure with Retro-view scope & New ESD Dvices~ |
Luncheon
Seminar35
GADELIUS MEDICAL K.K.
Plastic stent innovation part2 |
Luncheon
Seminar36
JIMRO Co., Ltd.
A non-drug treatment strategy in ulcerative colitis |
Luncheon
Seminar37
Eisai Co., Ltd. / EIDIA Co., Ltd.
How to manage the Intermediate and Advanced Stage HCC? |
No poster session
during Luncheon Seminars
(12:30-13:40) |
|
|
40 |
|
|
|
|
14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
W1(JSH/JSGE)
Recent development study and therapy for HBV infectionChair：
O. Yokosuka
K. Chayama |
Lecture by Congress President(JSH)
The way which I traced as a liver pathologistLecturer：
M. Kage
Chair：
K. Shiraki |
Integrated Program 2
(JDDW/JGES/JSGS)
Recent advances of laparoscopy and endoscopy corporative surgeryChair：
S. Natsugoe
N. Yahagi |
PD1(JSH/JSGE/JSGS)
Aiming for a consensus on combined hepatocellular and cholangiocarcinomaChair：
N. Kokudo
O. Nakashima |
Lecture by Congress President(JGES)
Endoscopy for H. pylori infectionLecturer：
M. Kato
Chair：
T. Suga |
IS-S2(JSGE/JGES)
Recent progress in IgG4-related pancreatobiliary diseasesChair：
K. Okazaki
S. Chari |
Live broadcast Room 1 |
Report(JSGCS)
Annual report of gastrointestinal cancer screening in Japan, 2013
Lecturer：
S. Kitagawa
Chair：
D. Shibuya |
PD4(JSGE/JSH/JSGS)
Therapeutic strategy for acute liver failure: Medical liaison between hepatologists and tranaplant surgeonsChair：
S. Kawasaki
S. Mochida |
PD6(JGES/JSGE)
Long term outcome of superficial head & neck cancer and esophageal cancer after endoscopic resectionChair：
M. Muto
K. Goda |
Special Lecture(JSGE)
Pretargeting antibody drug for diagnosis and treatment of advance colon cancerLecturer：
T. Kodama
Chair：
M. Imawari |
Live broadcast Room 2 |
Live broadcast Room 3 |
Digital Poster Session
(JSGE)
14:00
|
16:30 |
Digital Poster Session
(JSH)
14:00
|
16:30 |
Digital Poster Session
(JSGCS)
14:00
|
16:30 |
Digital Poster Session
(JGES)
14:00
|
16:30 |
ESD Hands-on seminar 1 (JGES)
JDDW ESD Hands-on seminar for Japanese endoscopists 1
Coordinator:
S. Oka |
|
|
40 |
|
S2(JSH/JSGE)
Pediatric hepatology - Present and future -Chair：
A. Matsui
A. Inui |
JGES Featured Session 1
(JGES)
The 90th Anniversary of JGES: Advance in medical treatment and technology with the gastrointestinal endoscopy - the history and futureChair：
N. Uemura
K. Fujimoto |
Special Lecture(JSGCS)
World trends in colorectal cancer screeningLecturer：
H. Saito
Chair：
M. Suyama |
|
|
15:00 |
|
S4(JSGE/JGES/JSGS)
Cooperation between internists and surgeons in the treatment of inflammatory bowel diseaseChair：
M. Watanabe
Y. Hashiguchi |
|
|
16:00 |
|
PD2(JSGCS/JSGE/JGES)
Ideal states of population-based gastric cancer screeningChair：
T. Itoh
Y. Iriguchi |
|
|
|
|
|
|
17:00 |
|
|
|
|
|
|
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18:00 |
|
Satellite
Symposium63
Olympus Corporation
History of ESD, endoscopic treatment in future |
No planned seminars |
No planned seminars |
Eastern District Council
(Japan Society
of Hepatology)
17:30-18:30 |
Satellite
Symposium64
FUJIFILM Medical Co., Ltd.
Vision of gastric cancer screening approach ～ Considering the gastric cancer screening guide line based on the efficacy assessment ～ |
Satellite
Symposium65
Gilead Sciences, Inc.
Recent Advance in the Treatment of Hepatitis C |
Satellite
Symposium66
Astellas Pharma Inc.
The forefront of IBS treatment |
Satellite
Symposium67
Astellas Pharma Inc.
Achievement of mucosal healing early stage in refractory ulcerative colitis -Treatment of tacrolimus- |
No planned seminars |
Satellite
Symposium68
Novartis Pharma K.K.
First GIST Patient -What do you do? |
Satellite
Symposium69
Chugai Pharmaceutical Co., Ltd.
How to achieve long-term amelioration in patients with chronic hepatitis B -the importance of interferon therapy. |
|
|
30 |
|
Setting up the JDDW Banquet Room |
|
|
|
|
|
|
|
19:00 |
|
|
|
|
|
|
|
30 |
|
Social Gathering (after the Satellite Seminar) |
|
|
|
|
|
|
|
|
45 |
|
|
|
|
|
|
|
|
|
20:00 |
|
|
|
| |
|
|
|
|
